巴克莱对10x基因组学公司(TXG)转为更乐观态度,尽管研究支出波动——雅虎财经英国版
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending - Yahoo Finance UK
生物技术与制药领域的最新动态
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending - Yahoo Finance UK
Futures Contracts for Lonza Group Futures - TradingView — Track All Markets
Canaccord Genuity Maintains 10x Genomics (TXG) Buy Recommendation - Nasdaq
6 people charged in $41M insider trading scheme tied to 2 biotechs
Cryptovaranoides is not a squamate
DendroTweaks, an interactive approach for unraveling dendritic dynamics
Trained Immunity: RoadMap for drug discovery and development
Predictive modeling of hematoma expansion from non-contrast computed tomography in spontaneous intracerebral hemorrhage patients
Are peer reviewers influenced by their work being cited?
GPR30 in spinal cholecystokinin-positive neurons modulates neuropathic pain
Functional genomics reveals strain-specific genetic requirements conferring hypoxic growth in Mycobacterium intracellulare
Mac-/Lactosylceramide regulates intestinal homeostasis and secretory cell fate commitment by facilitating Notch signaling
Computer prediction and genetic analysis identifies retinoic acid modulation as a driver of conserved longevity pathways in genetically diverse Caenorhabditis nematodes
Novo Nordisk eyes a strong launch with FDA approval of obesity pill
10x Genomics (TXG) Stock Trades Up, Here Is Why - Finviz
BioMarin quietly discards liver disease candidate after $4.8B Amicus announcement
Abbott’s Volt pulsed field ablation system scores FDA approval
CMS proposes two long-awaited Medicare drug pricing demos
China's new commercial insurance model could broaden access to Alzheimer's drugs
Bristol Myers brings IRA drug pricing fight to Supreme Court